The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cost benefit analysis of laboratory directed chemotherapy for advanced pancreatic cancer in U.S. and Brazilian patients.
 
Robert Alan Nagourney
Employment - Rational Therapeutics
Leadership - Rational Therapeutics
Stock and Other Ownership Interests - Rational Therapeutics
 
Rene Claudio Gansl
No Relationships to Disclose
 
Gilberto Lopes
Honoraria - AstraZeneca; Fresenius Kabi; Merck Serono; Merck Sharp & Dohme; Novartis; Roche/Genentech
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly/ImClone; Pfizer
Research Funding - AstraZeneca; Eisai; Lilly/ImClone; Merck Sharp & Dohme; Pfizer
Expert Testimony - Sanofi
 
Antonio C. Buzaid
No Relationships to Disclose
 
Fernando C. Maluf
No Relationships to Disclose
 
Paulo D'Amora
No Relationships to Disclose
 
Nise Hitomi Yamaguchi
No Relationships to Disclose
 
Fabricio Colacino Silva
No Relationships to Disclose
 
Andre Nebel De Mello
No Relationships to Disclose